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Clinical commentary
Evidence-based answer
What’s the best treatment  
for gestational diabetes?
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and Stephen Johnson, MlS
University of Wisconsin-Madison
Customize the intervention
Achieving	solid	glucose	control	for	patients	
with	gestational	diabetes	should	be	easy—
most	patients	are	healthy	and	motivated	
to	do	what	is	best	for	their	babies.	but	a	
new	diagnosis	and	blood	sugar	monitoring	
requirements	can	be	daunting.	lifestyle	
changes	and	medications	can	quickly	
add	to	the	sense	of	being	overwhelmed.	
Fortunately,	whatever	brings	down	the	
blood	sugar	will	do	as	therapy,	so	the	
patient	can	negotiate	with	her	doctor	
to	develop	an	intervention—be	it	diet,	
exercise,	oral	medications,	insulin,	or	a	
combination—that	works	for	her.
 
Jon O. neher, MD
valley	Family	medicine,	renton,	Wash
z 	Evidence summary
Findings from 2 studies support the no-
tion that the treatment of gestational 
diabetes decreases neonatal morbidity 
and mortality (TablE).1,2 Both studies 
found a decrease in neonatal morbidity 
and mortality for those patients treated 
either with diet or insulin. One study 
found a higher rate of NICU admission 
in the treatment group, but the authors 
attributed this to physician aware-
ness of the patient having gestational 
diabetes.1
Glyburide vs insulin
A high-quality randomized controlled 
trial comparing glyburide with in-
sulin among 404 women found no 
difference in maternal hypoglyce-
mia, neonatal mortality, or neona-
tal features and outcomes (including 
birthweight, NICU admissions, hy-
perbilirubinemia, and hypoglycemia; 
P ≥.25).3 Although this was a fairly large 
trial, it may have been underpowered 
since it found small differences in such 
rare outcomes.
Similarly, a retrospective study com-
paring glyburide with insulin in 584 
women found little difference between 
the 2 approaches. Women in the glybu-
ride group had better glycemic control, 
but the women in the insulin group 
started with higher initial blood sugars.4 
The glyburide group had fewer NICU 
admissions than the insulin group (num-
there	is	no	single	approach	to	glycemic	
control	that	is	better	than	another	for	
reducing	neonatal	mortality	and	morbidity.	
Glycemic	control—regardless	of	whether	
it	involves	diet,	glyburide,	or	insulin—leads	
to		fewer	cases	of	shoulder	dystocia,	
hyperbilirubinemia	requiring	phototherapy,	
nerve	palsy,	bone	fracture,	being	large	for	
gestational	age,	and	fetal	macrosomia	
(strength	of	recommendation:	A).	
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Diet, glyburide, 
and insulin all 
reduce neonatal 
morbidity and 
mortality from 
gestational  
diabetes
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ber needed to treat [NNT]=11), but 
higher rates of jaundice (number need-
ed to harm [NNH]=25), pre-eclampsia 
(NNH=17), and maternal hypoglycemia 
(NNH=8). All other neonatal outcomes 
were similar between groups. 
Diet alone vs diet + insulin
A meta-analysis combined 6 RCTs com-
paring diet alone with diet plus insulin 
in a total of 1281 women.5 Insulin was 
moderately superior to diet in prevent-
ing fetal macrosomia (NNT=11; 95% 
confidence interval, 6–36), but not 
in rates of hypoglycemia, hypocalce-
mia, hyperbilirubinemia, or congenital 
malformations.
Recommendations from others
The American Diabetes Association 
(ADA) recommends that women di-
agnosed with gestational diabetes by 
a 3-hour glucose tolerance test receive 
nutritional counseling from a registered 
dietician. The ADA also recommends 
insulin therapy if diet is unsuccessful in 
achieving fasting glucose <105 mg/dL, 
1-hour postprandial <155 mg/dL, or 
2-hour postprandial <130 mg/dL.6
The American College of Obste-
tricians and Gynecologists (ACOG) 
recommends the use of diet or insulin 
to achieve 1-hour postprandial blood 
sugar of 130 mg/dL.7 Both ADA and 
ACOG indicate that further studies 
are needed to establish the safety of 
glyburide before general use can be 
recommended. n
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Treatment of gestational diabetes reduces  
neonatal morbidity and mortality
TyPE of    nEonATAl morbidiTy 
sTudy ConTrol(s) inTErvEnTion And morTAliTy Admissions To niCu nnT
rCT1	 GDm	routine		 GDm	treated	with		 Control:	4%	 71%	diet	and	insulin		 34	
	 care	(N=510)	 diet	or	insulin		 Intervention:	1%		 vs	61%	routine	care	
	 	 (N=490)	 	 NNH:	100
Cohort2	 1)	No	GDm		 GDm	treated	 Control	1:	11%	 Not	reported	 2*	
	 (N=1110)	 diet	or	insulin	 Control	2:	59%
	 2)	GDm	not		
(N=1110)
	 Intervention:	15%	
	 treated	(due	to		
	 late	entry	to		
	 care)	(N=555)
*Compared	with	patients	presenting	late.
GDm,	gestational	diabetes	mellitus;	NNH,	number	needed	to	harm;	NNt,	number	needed	to	treat.
table
Insulin was better 
than diet for  
preventing fetal 
macrosomia,  
but rates of  
congenital  
malformations 
and hypoglycemia 
were similar
